Indications and uses
According to homeopathic indications these ingredients provide temporary relief from symptoms of Fibromyalgia such as: - Muscle Pain - Fatigue - Nerve/Soft Tissue Pain - Headache - Multiple Tender Points
Temporary Fibromyalgia Pain and Discomfort Relief
- Manufacturer
- TRP Company
- Effective date
- 2012-05-31
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:03:48
Label at a glance#
ProductTemporary Fibromyalgia Pain and Discomfort Relief
Active ingredientAconitum Napellus, Atropa Belladonna, Causticum, Magnesium Phosphate, Dibasic Trihydrate, Strychnos Nux-Vomica Seed, Toxicodendron Pubescens Leaf, Magnesium Ascorbate, Thiamine Hydrochloride, Riboflavin, Niacinamide, Pyridoxine Hydrochloride, Folic Acid, Cyanocobalamin, Biotin, Calcium Pantothenate, Magnesium Oxide, Selenium, Sedum Roseum Root
Label structure12 sections
Dosage and administration
Take 1 caplet, morning and evening, 5 minutes before or 20 minutes after a meal. Let the homeopathic external shell dissolve in your mouth until the sweetness is gone (approx. 20-40 seconds), then swallow the remaining vitamin enriched core with water. For faster results take 1 caplet 3 times per day. For best results, use for at least 6 months. After desired results are achieved, reduce dosing to 1 caplet 2 times...
Contacts and useful links#
Websitewww.trpcompany.com
www.trpcompany.com
www.trpcompany.comLabel contents#
Full prescribing information#
Homeopathic Purpose
| Aconitum Napellus | 6c/12c/18c | Acute Pain, Inflammation |
| Belladonna | 6c/12c/18c | Chronic Pain, Headache |
| Causticum | 6c/12c/18c | Muscle and Nerve Pain |
| Magnesium Phos | 6c/12c/18c | Cramping Pain, Fatigue |
| Nux Vomica | 6c/12c/18c | Sleeplessness, Irritable bowels |
| Rhus Toxicodendron | 6c/12c/18c | Joint and Soft Tissue Pain |
Active Ingredients
| Aconitum Napellus | 6c/12c/18c |
| Belladonna | 6c/12c/18c |
| Causticum | 6c/12c/18c |
| Magnesium Phos | 6c/12c/18c |
| Nux Vomica | 6c/12c/18c |
| Rhus Toxicodendron | 6c/12c/18c |
| Magnesium Ascorbate | 200 mg |
| Thiamine Hydrochloride | 1 mg |
| Riboflavin | 1 mg |
| Niacinamide | 20 mg |
| Pyridoxine Hydrochloride | 1 mg |
| Folic Acid | 400 mcg |
| Cyanocobalamin | 400 mcg |
| Biotin | 200 mcg |
| Calcium Pantothenate | 5 mg |
| Magnesium Ascorbate | 75 mg |
| Magnesium Oxide | 75 mg |
| Selenium | 100 mcg |
| Sedum Roseum Root | 200 mg |
Inactive Ingredients
| Microcrystalline cellulose |
| Polyvinyl Alcohol |
| Talc |
| Macrogol/PEG 3350 |
| Polysorbate 80 |
| Sodium Carboxymethylcellulose |
| Dextrin |
| Dextrose Monohydrate |
| Lecithin |
| Sodium Citrate |
| Stearic Acid |
| Croscarmellose |
| Magnesium Stearate |
| Silicon Dioxide |
| Sucralose |
Uses
According to homeopathic indications these ingredients provide temporary relief from symptoms of Fibromyalgia such as:
- Muscle Pain
- Fatigue
- Nerve/Soft Tissue Pain
- Headache
- Multiple Tender Points
Warnings
- Consult with your doctor prior to use if you are pregnant or nursing.
- Initial worsening of symptoms may occur.
- If symptoms persist or worsen, consult your doctor.
- Anyone experiencing widespread pain as with Fibromyalgia should see a doctor to determine if a specific treatment is needed or to make sure that it is not a sign of a serious underlying condition.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep this and all medicines out of reach of children.
Do not use
If tamper evident seal is broken.
Stop Use and See A Doctor If
If Symptoms persist for more than 7 days or worsen or if new symptoms occur or if redness or swelling is present because these could be a sign of a serious illness.
Directions
Take 1 caplet, morning and evening, 5 minutes before or 20 minutes after a meal.
Let the homeopathic external shell dissolve in your mouth until the sweetness is
gone (approx. 20-40 seconds), then swallow the remaining vitamin enriched core
with water. For faster results take 1 caplet 3 times per day. For best results,
use for at least 6 months. After desired results are achieved, reduce dosing to 1
caplet 2 times per day.
Other Information
If an initial worsening (healing aggravation) of symptoms occurs stop use until the
aggravations subsides, then continue taking the caplets.
OTC - QUESTIONS SECTION
TRP Company
1575 Delucchi Lane #115
Reno, NV 89502
888-969-6855
www.trpcompany.com
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 17312-004-12 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c4ee-f6ea-e053-dbdaa90aa703 | Temporary Fibromyalgia Pain and Discomfort Relief |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 17312-004-12 | Temporary Fibromyalgia Pain and Discomfort Relief | 1 in 1 Package | Tablet, Multilayer | 1 | 1 | |
| 17312-004-12 | Temporary Fibromyalgia Pain and Discomfort Relief | 60 in 1 Bottle | Tablet, Multilayer | 60 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 17312-004 | TEMPORARY FIBROMYALGIA PAIN AND DISCOMFORT RELIEF (ACONITUM NAPELLUS, ATROPA BELLADONNA, CAUSTICUM, MAGNESIUM PHOSPHATE, DIBASIC, STRYCHNOS NUX-VOMICA SEED, TOXICODENDRON PUBESCENS LEAF) TABLET, MULTILAYER [TRP COMPANY] | 1 | Legacy NDC, 2 package rows | 20120605_922107dd-bb24-4efe-b034-8296404da720.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Aconitum Napellus | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| Atropa Belladonna | ACTIVE INGREDIENT | WQZ3G9PF0H | 1 | |
| Biotin | ACTIVE INGREDIENT | 6SO6U10H04 | 1 | |
| Calcium Pantothenate | ACTIVE INGREDIENT | 568ET80C3D | 1 | |
| Causticum | ACTIVE INGREDIENT | DD5FO1WKFU | 1 | |
| Cyanocobalamin | ACTIVE INGREDIENT | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE INGREDIENT | 935E97BOY8 | 1 | |
| Magnesium Ascorbate | ACTIVE INGREDIENT | 0N1G678593 | 1 | |
| Magnesium Oxide | ACTIVE INGREDIENT | 3A3U0GI71G | 1 | |
| Magnesium Phosphate, Dibasic Trihydrate | ACTIVE INGREDIENT | HF539G9L3Q | 1 | |
| Niacinamide | ACTIVE INGREDIENT | 25X51I8RD4 | 1 | |
| Pyridoxine Hydrochloride | ACTIVE INGREDIENT | 68Y4CF58BV | 1 | |
| Riboflavin | ACTIVE INGREDIENT | TLM2976OFR | 1 | |
| Sedum Roseum Root | ACTIVE INGREDIENT | 3S5ITS5ULN | 1 | |
| Selenium | ACTIVE INGREDIENT | H6241UJ22B | 1 | |
| Strychnos Nux-Vomica Seed | ACTIVE INGREDIENT | 269XH13919 | 1 | |
| Thiamine Hydrochloride | ACTIVE INGREDIENT | M572600E5P | 1 | |
| Toxicodendron Pubescens Leaf | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| Aconitum Napellus | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| Atropa Belladonna | ACTIVE MOIETY | WQZ3G9PF0H | 1 | |
| Biotin | ACTIVE MOIETY | 6SO6U10H04 | 1 | |
| Calcium Pantothenate | ACTIVE MOIETY | 568ET80C3D | 1 | |
| Causticum | ACTIVE MOIETY | DD5FO1WKFU | 1 | |
| Cyanocobalamin | ACTIVE MOIETY | P6YC3EG204 | 1 | |
| Folic Acid | ACTIVE MOIETY | 935E97BOY8 | 1 | |
| Magnesium Ascorbate | ACTIVE MOIETY | 0N1G678593 | 1 | |
| Magnesium Cation | ACTIVE MOIETY | T6V3LHY838 | 1 | |
| Magnesium Oxide | ACTIVE MOIETY | 3A3U0GI71G | 1 | |
| Niacinamide | ACTIVE MOIETY | 25X51I8RD4 | 1 | |
| Pyridoxine | ACTIVE MOIETY | KV2JZ1BI6Z | 1 | |
| Riboflavin | ACTIVE MOIETY | TLM2976OFR | 1 | |
| Sedum Roseum Root | ACTIVE MOIETY | 3S5ITS5ULN | 1 | |
| Selenium | ACTIVE MOIETY | H6241UJ22B | 1 | |
| Strychnos Nux-Vomica Seed | ACTIVE MOIETY | 269XH13919 | 1 | |
| Thiamine Ion | ACTIVE MOIETY | 4ABT0J945J | 1 | |
| Toxicodendron Pubescens Leaf | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| Carboxymethylcellulose Sodium | INACTIVE INGREDIENT | K679OBS311 | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| Croscarmellose | INACTIVE INGREDIENT | 029TFK992N | 1 | |
| Dextrose Monohydrate | INACTIVE INGREDIENT | LX22YL083G | 1 | |
| Egg Phospholipids | INACTIVE INGREDIENT | 1Z74184RGV | 1 | |
| Icodextrin | INACTIVE INGREDIENT | 2NX48Z0A9G | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| Polyethylene Glycol 3350 | INACTIVE INGREDIENT | G2M7P15E5P | 1 | |
| Polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | 1 | |
| Polyvinyl Alcohol | INACTIVE INGREDIENT | 532B59J990 | 1 | |
| Silicon Dioxide | INACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| Sodium Citrate | INACTIVE INGREDIENT | 1Q73Q2JULR | 1 | |
| Stearic Acid | INACTIVE INGREDIENT | 4ELV7Z65AP | 1 | |
| Sucralose | INACTIVE INGREDIENT | 96K6UQ3ZD4 | 1 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Products#
Every source-derived product name is available through these pages.
- Temporary Fibromyalgia Pain and Discomfort Relief
- Aconitum Napellus, Atropa Belladonna, Causticum, Magnesium Phosphate, Dibasic, Strychnos Nux-Vomica Seed, Toxicodendron Pubescens Leaf
- Aconitum Napellus
- Atropa Belladonna
- Causticum
- Magnesium Phosphate, Dibasic Trihydrate
- Magnesium Cation
- Strychnos Nux-Vomica Seed
- Toxicodendron Pubescens Leaf
- Magnesium Ascorbate
- Thiamine Hydrochloride
- Thiamine Ion
- Riboflavin
- Niacinamide
- Pyridoxine Hydrochloride
- Pyridoxine
- Folic Acid
- Cyanocobalamin
- Biotin
- Calcium Pantothenate
- Magnesium Oxide
- Selenium
- Sedum Roseum Root
- Cellulose, Microcrystalline
- Polyvinyl Alcohol
- Talc
- Polyethylene Glycol 3350
- Polysorbate 80
- Carboxymethylcellulose Sodium
- Icodextrin
- Dextrose Monohydrate
- Egg Phospholipids
- Sodium Citrate
- Stearic Acid
- Croscarmellose
- Magnesium Stearate
- Silicon Dioxide
- Sucralose
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 17312-004 | 17312-004-12 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | SUSPENSION, EXTENDED RELEASE / ORAL | 71 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAMUSCULAR | 1 mg | ||
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | CREAM / TOPICAL | 396 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | GRANULE / ORAL | 629 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | LOZENGE / ORAL | 115 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CAPSULE / ORAL | 418.37 mg | ||
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | OINTMENT / TOPICAL | 1179 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CREAM / VAGINAL | 1088 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET / ORAL | 45 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | DROPS / ORAL | NA | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | CAPSULE / ORAL | 160 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SOLUTION/ DROPS / OPHTHALMIC | 0.25 %w/v | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | CAPSULE, EXTENDED RELEASE / ORAL | 168 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUPPOSITORY / VAGINAL | 28 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 53 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SPRAY, METERED / NASAL | 0.1 mg/1ml | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, DELAYED RELEASE PARTICLES / ORAL | 170 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | LX22YL083G | GRANULE, FOR SUSPENSION / ORAL | 15009 mg | ||
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | TABLET, EXTENDED RELEASE / ORAL | 61 mg | ||
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | LX22YL083G | INJECTION, EMULSION / INTRAMUSCULAR | 938 mg | ||
| Dextrose Monohydrate | DEXTROSE MONOHYDRATE | LX22YL083G | SPRAY, METERED / NASAL | 20 mg | ||
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION, SUSPENSION / SUBCUTANEOUS | 2.88 %w/v | ||
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | G2M7P15E5P | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 60 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, SUSPENSION / INTRAMUSCULAR | 30 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION, POWDER, FOR SUSPENSION / INTRAMUSCULAR | 25 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | TABLET / ORAL | 280 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | POWDER / ORAL | 602 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | NA | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | TABLET, FILM COATED / ORAL | 166 mg | ||
| Talc | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | POWDER, FOR SUSPENSION / ORAL | 400 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 9 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, DELAYED RELEASE / ORAL | 80 mg | ||
| Icodextrin | ICODEXTRIN | 2NX48Z0A9G | TABLET, DELAYED RELEASE / ORAL | 9.25 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | SOLUTION / OPHTHALMIC | 1 mg | ||
| Silicon Dioxide | SILICON DIOXIDE | ETJ7Z6XBU4 | INSERT / VAGINAL | 8 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | TABLET, EXTENDED RELEASE / ORAL | 200 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | PELLET / ORAL | 24 mg | ||
| Cellulose, Microcrystalline | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE / ORAL | 1725 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | TABLET, CHEWABLE / ORAL | 84 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | CAPSULE, EXTENDED RELEASE / ORAL | 117 mg | ||
| Sucralose | SUCRALOSE | 96K6UQ3ZD4 | TABLET, CHEWABLE / ORAL | 28 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| Polyvinyl Alcohol | POLYVINYL ALCOHOL | 532B59J990 | TABLET, COATED / ORAL | 0.7 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | SUSPENSION / OPHTHALMIC | 1 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | INJECTION / INTRASYNOVIAL | 0.1 %w/v | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | GRANULE, FOR SUSPENSION / ORAL | 15.63 mg/5ml | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | IMPLANT / SUBCUTANEOUS | 0.5 mg | ||
| Carboxymethylcellulose Sodium | CARBOXYMETHYLCELLULOSE SODIUM | K679OBS311 | POWDER, FOR SOLUTION / ORAL | 161 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| Egg Phospholipids | EGG PHOSPHOLIPIDS | 1Z74184RGV | INJECTION / INTRAVENOUS | 18000 mg | ||
| Polysorbate 80 | POLYSORBATE 80 | 6OZP39ZG8H | CONCENTRATE / INTRAVENOUS | 4680 mg | ||
| Stearic Acid | STEARIC ACID | 4ELV7Z65AP | CREAM / TOPICAL | 190 mg | ||
| Magnesium Stearate | MAGNESIUM STEARATE | 70097M6I30 | LOZENGE / TRANSMUCOSAL | 100 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dcbfff46-0e86-46be-b01e-b6bf9bf639ba | 922107dd-bb24-4efe-b034-8296404da720 | 2012-05-31 | Warnings | dcbfff46-0e86-46be-b01e-b6bf9bf639ba 922107dd-bb24-4efe-b034-8296404da720 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.